Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 358 participants.

Also called NCT07296744

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 358 participants (planned count) (from the registry)
Sponsor
Supira Medical (from the registry)
Registry
  • NCT NCT07296744
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
United States (from the registry)
Registry status
  • Recruiting (from the registry)

Technical summary

Registry record NCT07296744. Randomized; no masking; primary purpose treatment. Start 2026-05-11 (actual); primary completion 2027-11 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Pivotal Study of the SUpira System in Patients Undergoing High-Risk Percutaneous COronaRy InTervention (HRPCI)
Acronym
SUPPORT II
Condition
High Risk Percutaneous Coronary Intervention
Condition
Interventional Cardiology
Condition
Mechanical Circulatory Support
Intervention (Device)
The Supira System
Intervention (Device)
Impella
Lead sponsor
Supira Medical (class: industry)

Record details

Record id
cardio:ct-nct07296744
Content hash
4334b738c3047f02fcd4b1dd2d46c06f564ef6bffa42445c8b8c98e0ffb11be0